Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2012 August;64(4) > Minerva Ginecologica 2012 August;64(4):293-308

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

  PREECLAMPSIA


Minerva Ginecologica 2012 August;64(4):293-308

language: English

Role of ultrasound in pre-eclampsia

Jodicke C., Maulik Dev., Singh P., Heitmann E., Maulik Devika

Department of Obstetrics and Gynecology University of Missouri-Kansas City, School of Medicine, Kansas City, MO, USA


PDF  


Pre-eclampsia (PE), defined as de novo hypertension (>140/90 mmHg) appearing after 20 weeks of gestation accompanied by proteinuria (>0.3 g/24 h), remains a major source of perinatal growth restriction, prematurity and death worldwide. Since its introduction practitioners have increasingly utilized fetal ultrasonography for the management of pre-eclampsia. Ultrasonographic diagnostic modalities including fetal biometric growth curves, the biophysical profile and umbilical artery Doppler have been used to detect fetal growth restriction and assess fetal wellbeing, respectively. Doppler studies of the middle cerebral and uterine arteries offer additional utility in the prediction of adverse pregnancy outcomes and as a potential screening test for pre-eclampsia. The purpose of this review was to explore the developments of ultrasound technology that have been relevant to the screening, diagnosis and management of pre-eclampsia.

top of page

Publication History

Cite this article as

Corresponding author e-mail

cristiano.jodicke@tmcmed.org